Newsroom | 207261 results

LAKE FOREST, Calif.--(BUSINESS WIRE)--STAAR Surgical Company (NASDAQ: STAA), the global leader in phakic IOLs with the EVO family of Implantable Collamer® Lenses (EVO ICL™) for vision correction, today announced that the Company has agreed with Alcon Inc. (SIX/NYSE: ALC) to amend their merger agreement to allow proactive solicitation by STAAR of third-party proposals to maximize value for all STAAR stockholders. The amended agreement includes: A new 30-day go-shop period: The new go-shop period...

WINTER PARK, Fla.--(BUSINESS WIRE)--Humata Health, the leader in AI-powered prior authorization technology, has been selected by the Centers for Medicare & Medicaid (CMS) as a key partner for its WISeR model, an initiative focused on safeguarding patients and protecting Medicare funds. Humata will use its proprietary technology to help build a more modern, efficient and fair clinical approval process for CMS, the single largest payer for healthcare in the U.S. The WISeR model — which launch...

HOUSTON--(BUSINESS WIRE)--CrossBridge Bio, a biopharmaceutical company pioneering next-generation dual-payload antibody-drug conjugates (ADCs) that have the potential to deliver safer more durable responses in patients, including those resistant to approved ADC therapies, today announced that it has been named the Winner of “Best Drug Developer” at the 2025 World ADC Awards. CrossBridge Bio was selected from a competitive global field by a panel of independent ADC experts and peers. The award r...

EDMONTON, AB--(BUSINESS WIRE)--The Canadian Union of Public Employees Alberta Division (CUPE Alberta) has launched a website and advertising campaign asking the province’s conservative government to “axe the tax” on COVID vaccines. CUPE has launched a website at www.axethevaxtax.ca, which allows Albertans to send a letter to Premier Danielle Smith, NDP leader Naheed Nenshi, and their local MLA protesting the $100 fee charged to Albertans getting a COVID vaccination. CUPE is also advertising on...

DUBLIN--(BUSINESS WIRE)--The "United States Fair-Market Value Compensation Rates for Infectious Diseases KOLs" report has been added to ResearchAndMarkets.com's offering. This report presents fair-market value (FMV) hourly and half-day compensation rates for US-based KOLs in the Infectious Diseases specialty, by percentiles, with averages, for four (4) levels of Thought Leader influences (rare, international, national and local). These defensible market-based rate data are built directly from i...

DUBLIN--(BUSINESS WIRE)--The "United States Fair-Market Value Compensation Rates for Internal Medicine KOLs" report has been added to ResearchAndMarkets.com's offering. This report presents fair-market value compensation rates for US-based KOLs within Internal Medicine roles, by percentiles, with averages, for four (4) levels of Thought Leader influences (rare, international, national, and local). These defensible market-based rate data are built directly from industry compensation paid to Heal...

LARKSPUR, Calif.--(BUSINESS WIRE)--Aulos Bioscience, an immuno-oncology company working to revolutionize cancer care through development of its lead immune-activating antibody therapeutic imneskibart (AU-007), today presented promising new Phase 2 data from its ongoing study of imneskibart in patients with checkpoint inhibitor (CPI)-refractory melanoma and non-small cell lung cancer (NSCLC). The data were shared in a poster session at the Society for Immunotherapy of Cancer (SITC) 40th Annual M...

CARLSBAD, Calif.--(BUSINESS WIRE)--Alphatec Holdings, Inc. (Nasdaq: ATEC) (“ATEC”), a provider of innovative solutions dedicated to revolutionizing the approach to spine surgery, today announced with great sadness that Jeffrey P. Rydin, a valued member of its Board of Directors, has passed away at age 59, following a lengthy illness. Mr. Rydin enjoyed nearly three decades of experience in the medical device and healthcare industries, including senior sales leadership roles at Ellipse Technologi...

BERKELEY HEIGHTS, N.J.--(BUSINESS WIRE)--Summit Health is proud to announce that 55 outstanding physicians have been recognized as 2025 Jersey Choice “Top Doctors” by New Jersey Monthly magazine. This esteemed accolade highlights the exceptional expertise, dedication, and compassionate care our doctors bring to the communities they serve. “Our physicians’ commitment to excellence in patient care is truly inspiring,” said Adam Barrison, MD, Chief Physician Executive of Summit Health and Starling...

WILMINGTON, Del.--(BUSINESS WIRE)--Positive full results from the NATRON Phase III trial showed AstraZeneca’s FASENRA (benralizumab) demonstrated a statistically significant delay in the time to first worsening or flare in hypereosinophilic syndrome (HES),1 a rare disease driven by elevated eosinophils.2 These data will be presented at the American College of Allergy, Asthma and Immunology (ACAAI) 2025 Annual Scientific Meeting in Orlando, Florida. Hypereosinophilic Syndrome (HES) is a group of...